Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen

NCT02475382 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Squamous Non-Small Cell Lung Cancer
Non-squamous Non-Small Cell Lung Cancer

Interventions

DRUG: Nivolumab

Sponsor

Bristol-Myers Squibb